미국의 심전도(ECG) 장비 시장 규모, 점유율 및 동향 분석 보고서 : 유형별, 최종 용도별, 부문별 예측(2023-2030년)

U.S. ECG Equipment Market Growth & Trends:

The U.S. ECG equipment market size is expected to reach USD 3.31 billion by 2030, registering a CAGR of 6.5% from 2023 to 2030, according to a new report by Grand View Research, Inc. Rise in prevalence of cardiovascular diseases in the country, availability of various monitoring devices, and technological advancements are among key factors driving the U.S. electrocardiograph device market.

Increase in investment by various market players and the U.S. government for development and commercialization of various easy-to-use equipment is also likely to drive the market. For instance, in September 2017, the U.S. FDA approved an app-driven, easy-to-clean, and fully reusable ECG device manufactured by NimbleHeart. The device can be wrapped around a user's torso and used without electrolytic gels and adhesives. Hence, it can be cleaned easily, thereby making the product ideal for multi-patient use.

In May 2018, Preventice Solutions launched BodyGuardian Mini, a reusable long-term and smallest Holter technology for cardiac monitoring. The new technology includes an ultra-small cardiac monitor that can measure ECG up to 14 days and can transfer data to a physician in an easy-to-read report. Hence, launch of such technologically advanced products to address the needs of physicians and patients is expected to boost market growth in the coming years.

U.S. ECG Equipment Market Report Highlights:

• The resting electrocardiograph segment accounted for the largest revenue share of 46.3% in 2022, owing to a better exchange of information through Cardiovascular Information Systems (CVIS) and electronic health records, which simplifies ECG workflow and reduces the complexity associated with integration
• The Holter monitoring system segment is expected to expand at the fastest CAGR of 7.6% from 2023 to 2030. This can be attributed to the commercialization of various products in recent years and increased demand by physicians and patients due to their portable nature
• Hospitals held the highest market share of around 39% in 2022, as the majority of patients rely on hospitals rather than other healthcare facilities due to the availability of well-equipped devices and the latest monitoring software
• Electrocardiograph equipment is frequently used in hospitals, ambulatory care centers, and other settings. The other end-uses segment is expected to register significant CAGR over the forecast period from 2023 to 2030
• Several players in the ECG equipment market in the U.S. are focusing on product approvals, regional expansions, and formation of partnerships to add new and innovative products to their portfolio and increase their market share

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Type
  • 1.1.2. End-use
  • 1.1.3. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type outlook
  • 2.2.2. End-use outlook
• 2.3. Competitive Insights

Chapter 3. U.S. ECG Equipment Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Market Dynamics
  • 3.3.1. Market Driver Analysis
  • 3.3.2. Market Restraint Analysis
• 3.4. U.S. ECG Equipment Market Analysis Tools
  • 3.4.1. Industry Analysis - Porter's Five Forces
    • 3.4.1.1. Supplier power
    • 3.4.1.2. Buyer power
    • 3.4.1.3. Substitution threat
    • 3.4.1.4. Threat of new entrant
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Technological landscape
    • 3.4.2.3. Economic Landscape

Chapter 4. U.S. ECG Equipment Market: Type Estimates & Trend Analysis

• 4.1. U.S. ECG Equipment Market: Key Takeaways
• 4.2. U.S. ECG Equipment Market: Type Movement & Market Share Analysis, 2022 & 2030
• 4.3. Resting ECG Systems
  • 4.3.1. Resting ECG systems market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.4. Holter Monitors
  • 4.4.1. Holter monitors market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.5. Stress ECG Monitors
  • 4.5.1. Stress ECG monitors market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.6. Event Monitoring System
  • 4.6.1. Event monitoring system market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. U.S. ECG Equipment Market: End-use Estimates & Trend Analysis

• 5.1. U.S. ECG Equipment Market: Key Takeaways
• 5.2. U.S. ECG Equipment Market: End-use Movement & Market Share Analysis, 2022 & 2030
• 5.3. Hospitals
  • 5.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.4. Ambulatory Care
  • 5.4.1. Ambulatory care market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.5. Others
  • 5.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Competitive Landscape

• 6.1. Recent Developments & Impact Analysis, By Key Market Participants
• 6.2. Company/Competition Categorization
  • 6.2.1. BioTelemetry, Inc.
    • 6.2.1.1. Company overview
    • 6.2.1.2. Financial performance
    • 6.2.1.3. Product benchmarking
    • 6.2.1.4. Strategic initiatives
  • 6.2.2. CompuMed, Inc.
    • 6.2.2.1. Company overview
    • 6.2.2.2. Financial performance
    • 6.2.2.3. Product benchmarking
    • 6.2.2.4. Strategic initiatives
  • 6.2.3. GE HealthCare
    • 6.2.3.1. Company overview
    • 6.2.3.2. Financial performance
    • 6.2.3.3. Product benchmarking
    • 6.2.3.4. Strategic initiatives
  • 6.2.4. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • 6.2.4.1. Company overview
    • 6.2.4.2. Financial performance
    • 6.2.4.3. Product benchmarking
    • 6.2.4.4. Strategic initiatives
  • 6.2.5. Hill-Rom Services, Inc.
    • 6.2.5.1. Company overview
    • 6.2.5.2. Financial performance
    • 6.2.5.3. Product benchmarking
    • 6.2.5.4. Strategic initiatives
  • 6.2.6. NIHON KOHDEN CORPORATION
    • 6.2.6.1. Company overview
    • 6.2.6.2. Financial performance
    • 6.2.6.3. Product benchmarking
    • 6.2.6.4. Strategic initiatives
  • 6.2.7. Schiller AG
    • 6.2.7.1. Company overview
    • 6.2.7.2. Financial performance
    • 6.2.7.3. Product benchmarking
    • 6.2.7.4. Strategic initiatives
  • 6.2.8. Koninklijke Philips N.V.
    • 6.2.8.1. Company overview
    • 6.2.8.2. Financial performance
    • 6.2.8.3. Product benchmarking
    • 6.2.8.4. Strategic initiatives
  • 6.2.9. CardioComm Solutions, Inc.
    • 6.2.9.1. Company overview
    • 6.2.9.2. Financial performance
    • 6.2.9.3. Product benchmarking
    • 6.2.9.4. Strategic initiatives
  • 6.2.10. McKesson Corporation
    • 6.2.10.1. Company overview
    • 6.2.10.2. Financial performance
    • 6.2.10.3. Product benchmarking
    • 6.2.10.4. Strategic initiatives